Reference no: EM132445380
Project questions
Question 1
On 1 October 2015, Zanda Co acquired 60% of Medda Co's equity shares by means of a share exchange of one new share in Zanda Co for every two acquired shares in Medda Co. In addition, Zanda Co will pay a further $0·54 per acquired share on 30 September 2016. Zanda Co has not recorded any of the purchase consideration and its cost of capital is 8% per annum. The market value of Zanda Co's shares at 1 October 2015 was $3·00 each. The summarised statements of financial position of the two companies as at 31 March 2016 are:
|
|
Zanda Co
$000
|
Medda Co
V000
|
|
Assets
|
|
|
|
Noncurrent assets
|
|
|
|
Property, plant and equipment (note 0))
|
25,400
|
13.500
|
|
Financial asset equity investments (note (n.f))
|
5.500
|
2.000
|
|
|
30.900
|
15,500
|
|
Current assets
|
|
|
|
Inventory (note (iil))
|
12.700
|
5.300
|
|
Other current assets
|
9,700
|
4,000
|
|
|
22.400
|
9.300
|
|
Total assets
|
53.300
|
24.800
|
|
Equity and liabilities
|
|
|
|
Equity
|
|
|
|
Equity shares of SI each
|
20.000
|
9 MO
|
|
Retained earnings:
|
|
|
|
&ought forward at 1 April 2015
|
12.200
|
8,600
|
|
Profit/(Ioss) for the year ended 31 March 2016
|
5.000
|
(3.000)
|
|
|
37.200
|
14.600
|
|
Non-current liabilities
|
|
|
|
Deferred tax (note 0))
|
5,000
|
nil
|
|
Current liabilities
|
11,100
|
10,200
|
|
Total equity and liabilities
|
53,300
|
24.800
|
The following information is relevant:
(i) At the date of acquisition, Zanda Co conducted a fair value exercise on Medda Co's net assets which were equal to their carrying amounts (including Medda Co's financial asset equity investments) with the exception of an item of plant which had a fair value of $2·5 million below its carrying amount. The plant had a remaining useful life of 30 months at 1 October 2015. The directors of Zanda Co are of the opinion that an unrecorded deferred tax asset of $1·2 million at 1 October 2015, relating to Medda Co's losses, can be relieved in the near future as a result of the acquisition. At 31 March 2016, the directors' opinion has not changed, nor has the value of the deferred tax asset.
(ii) Zanda Co's policy is to value the non-controlling interest at fair value at the date of acquisition. For this purpose, a share price for Medda Co of $1·50 each is representative of the fair value of the shares held by the non-controlling interest.
(iii) At 31 March 2016, Medda Co held goods in inventory which had been supplied by Zanda Co at a mark-up on cost of 35%. These goods had cost Medda Co $2·43 million.
(iv) The financial asset equity investments of Zanda Co and Medda Co are carried at their fair values at 1 April 2015. At 31 March 2016, these had fair values of $6·1 million and $1·8 million respectively, with the change in Medda Co's investments all occurring since the acquisition on 1 October 2015.
(v) There is no impairment to goodwill at 31 March 2016.
Required:
Prepare the Consolidated Financial statement and extracts from the consolidated statement of financial position of Zanda Co as at 31 March 2016:
(i) Goodwill;
(ii) Retained earnings;
(iii) Non-controlling interest.